Outcome of Board Meeting and Audited Financial Result For The Year Ended March 31 2018 General Announcement Filing viewer · member access Original SGX announcement
GPL announces grant of substitution and successful launch of generic Seretide Accuhaler in Denmark General Announcement Filing viewer · member access Original SGX announcement
Board Meeting on May 29 2018 General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives ANDA approval for Tacrolimus Ointment, 0.1 per. General Announcement Filing viewer · member access Original SGX announcement
GPL Announces Initiation of a Phase 2b Trial of GBR 830 for the Treatment of Atopic Dermatitis General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals and Helsinn Group enter into an exclusive licensing agreement General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Spray, 0.05% General Announcement Filing viewer · member access Original SGX announcement
Glenmark Presents New Data on Ryaltris an Investigational Product General Announcement Filing viewer · member access Original SGX announcement
Rating by S&P Global Ratings General Announcement Filing viewer · member access Original SGX announcement
Third Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Preliminary Biomarker Data on GBR 1302, a HER2xCD3 Bispecific Monoclonal Antibody General Announcement Filing viewer · member access Original SGX announcement
J. P. Morgan Healthcare Conference, San Francisco, USA Presentation General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceutical launches the biosimilar of Adalimumab in India General Announcement Filing viewer · member access Original SGX announcement
Successful closure of the decentralised registration procedure (DCP) for generic Seretide Accuhaler General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for HAILEYTM Fe 1/20 General Announcement Filing viewer · member access Original SGX announcement
ANDA approval for HAILEYTM 24 Fe and Ferrous Fumarate Tablets), 1 mg/20 mcg General Announcement Filing viewer · member access Original SGX announcement
Appointment of Chief Financial Officer (CFO) General Announcement Filing viewer · member access Original SGX announcement
Half Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Board Meeting on November 2, 2017 General Announcement Filing viewer · member access Original SGX announcement
ANDA approval for Aprepitant Capsules USP, 40 mg, 80 mg, and 125 mg General Announcement Filing viewer · member access Original SGX announcement
Proceedings and Voting Results of the 39th Annual General Meeting of Glenmark Pharmaceuticals Ltd General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Desonide Lotion, 0.05% General Announcement Filing viewer · member access Original SGX announcement
Notice - 39th Annual General Meeting General Announcement Filing viewer · member access Original SGX announcement
39th Annual General Meeting - September 29, 2017 General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Acyclovir Ointment USP, 5% General Announcement Filing viewer · member access Original SGX announcement